If you’re choosing between a cross-purchase and an entity redemption buy-sell, here’s the short answer: a cross-purchase works best when you have a small number of owners, relatively stable ownership, and you actually want the surviving owners (not the company) to end up owning more of the business. If you have lots of owners, you plan to raise venture capital, or you want something that scales cleanly over time, a straight cross-purchase often becomes more operationally annoying than founders expect.
The biggest misconception is thinking “cross-purchase” just means “the other founders buy the departing founder’s shares.” That’s the headline, but the real work is in the plumbing: funding, taxes, who signs what, and how you keep the plan from collapsing the first time someone leaves under less-than-ideal circumstances.
This shows up in real startup law not because it’s fancy, but because it’s one of the few documents that’s supposed to function when everything else is going sideways.
Why this comes up in real startup situations (not just closely held businesses)
Most early-stage startups don’t have a traditional buy-sell agreement on day one. They have founder stock purchase agreements, vesting, maybe a right of first refusal (ROFR), maybe a co-sale agreement, and they call it a day.
Then something changes. A founder wants out. Someone gets divorced. Someone has a medical issue. The company is doing well enough that the equity is worth arguing about. Or a future investor (venture or strategic) starts asking, “What happens if one of you disappears?”
A buy-sell agreement is basically your attempt to answer that question without improvising under time pressure.
Cross-purchase buy-sells are one of the classic solutions. They also have a classic failure mode: they look simple until you try to operate them.
The common founder assumption (and why it’s incomplete)
The common assumption is: “If a founder leaves, the other founders should be able to buy their shares so the cap table stays clean.”
That’s a reasonable instinct. It also skips over two things that drive outcomes in real deals:
Do the remaining owners actually have the cash (or insurance) to buy the shares when the trigger event happens?
Do you really want the remaining owners to buy directly, or do you want the company to buy and retire the shares?
The cross-purchase model hard-codes a particular answer: the other owners buy.
Sometimes that’s exactly right. Sometimes it creates friction you didn’t plan for, especially as you add investors, employees, and different classes of stock.
How a cross-purchase buy-sell works (plain English)
In a cross-purchase buy-sell, the owners agree that if certain events happen (death, disability, termination, retirement, deadlock, etc.), the remaining owners will buy the departing owner’s equity (or have the right/obligation to do so) directly.
Key features:
Buyer: the other owners (not the company)
Result: the remaining owners increase their ownership percentage
Funding: often personal funds, installment payments, or life/disability insurance
Documentation: the company is usually still involved administratively, but it’s not the purchaser
Contrast that with an entity redemption (also called a “stock redemption” in a corporation context), where the company buys back the shares and retires them (or holds them as treasury stock, depending on structure).
The cross-purchase structure tends to be more “owner-to-owner.” It can be cleaner on certain tax outcomes, and it can align with a “this is our company” mindset. But it shifts the burden onto individuals.
The three decisions you’re really making
Most cross-purchase negotiations are secretly about three questions:
Triggers: when does the buy-sell turn on?
Price: what is the purchase price, and how is it determined?
Funding and timing: who pays, when, and with what money?
If you don’t solve #3, the rest is theater.
Where cross-purchase tends to work well
1) Small number of owners (usually 2–5)
Cross-purchase scales badly. With two founders, it’s straightforward: A buys B, or B buys A. With three or four, you can still do it with proportional purchases.
With 15 shareholders, it’s a signature and logistics nightmare, and you’ll eventually redesign it.
So if you’re early, tightly held, and expect to stay that way for a while, cross-purchase can be a good fit.
2) You care who ends up owning more (economics and control)
In a cross-purchase, the owners who remain directly increase their percentage. That matters if:
Voting control is sensitive
You want ownership to stay within a founder group
You don’t want the company’s balance sheet involved
If you’re trying to avoid a scenario where the company redeems shares and an outside investor’s percentage increases “by math,” cross-purchase gives you a different lever.
3) Life insurance funding actually makes sense
Cross-purchase is commonly paired with life insurance: each owner (or the group) insures the others, and the proceeds fund the purchase if someone dies.
This is one of the few times where the “just buy insurance” advice isn’t naive—if the ownership group is small and the economics are stable enough to underwrite.
It’s also one of the few times where a buy-sell can actually work the way it reads on paper.
Where founders over-optimize (and what matters more)
Founders love to over-optimize the pricing mechanism. They’ll debate for hours whether the agreement should use a formula, a third-party appraisal, a board-set price, or last-round valuation.
In practice, the pricing clause is not what breaks most buy-sells.
What breaks them is:
nobody can afford to fund the purchase when it triggers, or
the trigger event is messy (termination for cause, deadlock, “constructive resignation,” etc.), or
the agreement requires too many people to sign too many documents too quickly.
If you’re going to spend your energy somewhere, spend it on funding and operational mechanics.
The hard part: “cross-purchase” sounds simple until you add real-world complications
Here are three concrete scenarios that come up in deal rooms.
Example 1: The “we raised venture” problem
You started with two or three founders. A cross-purchase felt clean. Then you raised venture financing, issued preferred stock, created an option pool, and now you have institutional investors who care about:
transfer restrictions,
consent rights,
protective provisions,
and not accidentally triggering weird tax or securities issues.
A classic cross-purchase can collide with later venture documents if it’s not drafted to coexist with them.
The practical point: venture investors don’t love bespoke owner-to-owner purchase obligations floating around unless they’re clearly subordinated to the financing documents and don’t create surprise liquidity rights.
If you’re venture-bound, you can still have founder buy-sell concepts, but they’re often handled through a mix of vesting, repurchase rights, and ROFR/co-sale structures rather than a full traditional cross-purchase.
Example 2: The “too many owners” paperwork blow-up
Suppose you have 8 shareholders (founders + early employees who exercised options). One shareholder leaves and the buy-sell triggers.
In a cross-purchase, every remaining owner may need to:
agree on price,
sign purchase docs,
wire funds (or sign notes),
update cap table records,
coordinate tax forms and basis tracking.
If even one person is slow, the whole process drags.
Entity redemption is often operationally easier because there’s a single buyer: the company.
Example 3: The “I can’t pay you, but I’m supposed to buy you out” moment
This is the most common real failure mode: the agreement says a buyout must happen, but nobody has liquid cash.
So you end up renegotiating the deal at the exact moment the agreement was supposed to prevent renegotiation.
Cross-purchase makes this more likely because the funding burden sits with individuals, not the business. If the company is profitable and can fund a redemption over time, redemption may be more realistic. If the company is not profitable, neither structure solves the core issue—there’s no money—but cross-purchase doesn’t magically create it.
Theory vs. reality: cross-purchase “protects the company” … until it doesn’t
The theoretical selling point is: “Cross-purchase keeps the company out of it. The company doesn’t spend cash buying shares. The owners handle it.”
In reality, the company is often involved anyway because:
the company’s equity records and approvals are required,
the company may need to consent to transfers under its charter/investor documents,
and the company will often be the one coordinating the process (because founders are busy and nobody wants a side project called ‘cap table surgery’).
Also, cross-purchase doesn’t avoid business disruption if the reason for the buy-sell is contentious. A deadlock-triggered buy-sell is never just a clean transaction. It’s a controlled demolition, and the documents determine how controlled it actually is.
So yes, cross-purchase can reduce direct company cash use. But it can increase operational and relational complexity, especially if you’re not tightly held.
The sports analogy (negotiating leverage and incentives)
A cross-purchase buy-sell is like calling a play that requires perfect timing between multiple players.
If you’ve got a small, disciplined roster, it can be beautiful. If you’ve got a roster that changes every season and you’re trying to run it under pressure, it turns into missed assignments.
Entity redemption is more like a play designed around one ball-handler: fewer moving parts, easier execution. Not always better economics, but often better reliability.
That reliability point matters because buy-sells are triggered at the worst moments, not the best ones.
Practical drafting points that matter more than founders expect
If you’re using a cross-purchase structure, these are the deal terms that usually drive outcomes:
1) Make the trigger events realistic and well-defined
“Death” is clear. “Disability” is not, unless you define it (often by reference to an insurance definition or a time-based inability to perform services).
“Termination for cause” sounds clear until you’re litigating what “cause” means. If you include fault-based triggers, expect friction.
2) Decide whether it’s a right, an obligation, or a waterfall
Some agreements make cross-purchase mandatory. Others make it optional (a right of first refusal concept). A common approach is a waterfall:
remaining owners have the right to buy (pro rata or as they agree), then
the company has the right to redeem the remainder, then
if neither happens, transfers are restricted and you fall back to a default (installment note, holdback, etc.)
That kind of structure acknowledges reality: sometimes individuals can buy, sometimes only the company can, and sometimes nobody can.
3) Funding mechanics: insurance, notes, and time
If you don’t have insurance, you probably need installment payments. If you use installment payments, you need to define:
down payment (if any),
term,
interest rate,
security (if any),
and what happens on default.
And you should be honest: if the purchase price is meaningful, you’re building a mini lending arrangement among founders. That’s not inherently bad, but it is what it is.
4) Coordinate with your other startup law documents
If you’re a corporation with venture financing documents, you need to ensure the buy-sell doesn’t conflict with:
ROFR/co-sale provisions,
investor consent rights,
transfer restrictions in the charter,
and any employment/vesting repurchase rights.
This is where a startup lawyer earns their fee: not by describing cross-purchase generally, but by making sure your particular stack of agreements doesn’t fight itself.
Where leverage and stage change the answer
Pre-seed / seed (founder-controlled)
If you and your co-founders control the company and the cap table is simple, cross-purchase can be a reasonable solution—especially for death/disability scenarios.
But if you’re trying to solve “what if a founder quits,” vesting and repurchase rights often do more work with less complexity than a full cross-purchase.
Priced venture rounds and beyond (investor-influenced)
Once you have institutional venture investors, your room to install bespoke mechanisms shrinks. Not because investors are mean, but because they’re optimizing for predictability and consistency across portfolio companies.
At that stage, buy-sell concepts that materially move equity often need to be integrated with the charter and investor rights, and many companies lean away from classic cross-purchase obligations because of administration and consent issues.
M&A context (acquirers care about “can you actually deliver the cap table you say you have?”)
In acquisitions, a buy-sell can matter in two ways:
It can reassure an acquirer that ownership transitions won’t create surprise third-party owners.
It can create diligence issues if the buy-sell has been triggered in the past but not followed (or followed inconsistently).
Acquirers love clean records. Buy-sells sometimes create messy ones if they’re not executed properly.
The practical takeaway
If you remember one thing, remember this: a cross-purchase buy-sell is only “simple” when the ownership group is small and the funding plan is real. If you can’t point to where the money comes from, you don’t have a buy-sell—you have a document that will be ignored at the worst possible time.
If you’re early-stage and founder-owned, you can use cross-purchase thoughtfully (often focused on death/disability) and rely on vesting/repurchase/ROFR mechanics for the more common “founder leaves” scenario.
If you’re scaling, adding lots of shareholders, or heading into venture financing, you should assume you’ll either (a) heavily customize the approach or (b) move toward a structure that the company can actually administer without herding cats.
FAQ (the ones you’ll actually ask a startup lawyer)
Is cross-purchase better than entity redemption?
Neither is universally “better.” Cross-purchase is often better when you want the remaining owners to directly increase their ownership and you can fund it. Redemption is often better when you want a single buyer (the company) for operational simplicity.
Can a cross-purchase work in a venture-backed startup?
Sometimes, but it usually needs to be coordinated carefully with your charter and investor rights, and many companies prefer simpler transfer restrictions plus vesting and repurchase rights instead of a classic buy-sell.
What’s the number one mistake with buy-sell agreements?
Writing a clean mechanism for price and triggers while ignoring funding and execution. The agreement doesn’t “solve” the problem if nobody can afford to follow it.
Ryan RobertsStartup Lawyer
Ryan Roberts is a startup lawyer with more than two decades of experience advising on venture financings and M&A transactions totaling more than $1 billion. He is the author of the Amazon bestselling startup law book Acceleration.
